Kyverna Therapeutics Inc (KYTX)

Finanzdaten der Kyverna Therapeutics Inc-Aktie (KYTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	4.38%39.56	41.37	39.28	38.73	44.41
Research and Development	17.57%24.79	30.07	30.01	30.46	35.82
Depreciation and Amortization	50.00%0.30	0.20	-	0.30	0.30
Operating Income/Loss	4.38%-39.56	-41.37	-39.28	-38.73	-44.41
Nonoperating Income/Loss	24.53%1.24	1.64	1.48	1.94	2.33
	3.55%-38.32	-39.73	-37.80	-36.79	-42.08
Attributable To Parent	3.55%-38.32	-39.73	-37.80	-36.79	-42.08
Basic Average Shares	0.77%60.90	60.43	-	43.42	43.23
Diluted Average Shares	0.77%60.90	60.43	-	43.42	43.23
Basic Earnings Per Share	4.55%-0.63	-0.66	-	-0.85	-0.97
Diluted Earnings Per Share	4.55%-0.63	-0.66	-	-0.85	-0.97